74%
jaeinvestorite kontodest jääb selle teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse.
Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. CFD-d on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti.
74%
jaeinvestorite kontodest jääb selle teenusepakkuja juures CFD-dega kauplemisel kahjumisse.
Palume teil kaaluda, kas CFD-de toimimine on teile arusaadav ja kas te olete valmis võtma riski, mis suure tõenäosusega on kahjumlik.
74%
jaeinvestorite kontodest jääb selle teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse.
Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. CFD-d on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti.
74%
jaeinvestorite kontodest jääb selle teenusepakkuja juures CFD-dega kauplemisel kahjumisse.
Palume teil kaaluda, kas CFD-de toimimine on teile arusaadav ja kas te olete valmis võtma riski, mis suure tõenäosusega on kahjumlik.
Cardinal Health Inc
Suletud
SektorTervishoid
135.79 1.02
Ülevaade
Aktsiahinna muutus
24h
Min
133.1
Max
136.18
Sissetulek | -15M 401M |
|---|---|
Müük | 3B 55B |
P/E Sektori keskmine | 24.426 57.333 |
Aktsiakasum | 1.93 |
Dividenditootlus | 1.5 |
Kasumimarginaal | 0.726 |
Töötajad | 47,922 |
EBITDA | -206M 549M |
Soovitused | Osta |
|---|---|
12 kuu keskmine prognoos | +7.72% upside |
Dividenditootlus Sektori keskmine | 1.50% 2.63% |
|---|---|
Järgmine tulemuste avaldamine | 1. mai 2025 |
Järgmine dividendimakse kuupäev | 14. juuli 2025 |
Järgmine aktsia dividendi kuupäev (ex-date) | 30. juuni 2025 |
Turukapital | 1.8B 32B |
|---|---|
Eelmine avamishind | 134.77 |
Eelmine sulgemishind | 135.79 |
Tehniline skoor
By Trading Central
Kindlus
Very Strong Bullish Evidence
Cardinal Health Inc Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Seotud uudised
Võrdlus sarnastega
Hinnamuutus
Cardinal Health Inc Prognoos
Hinnasiht
By TipRanks
7.72% tõus
12 kuu keskmine prognoos
Keskmine 146.33 USD 7.72%
Kõrge 161 USD
Madal 131 USD
Põhineb 13 Wall Streeti analüütiku instrumendi Cardinal Health Inc 12 kuu hinnasihil - viimase 3 kuu andmed.
Finantsandmed
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Intressikulud võla pealt
EBITDA
Ärikasum
$
Ettevõttest Cardinal Health Inc
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products, as well as medical supplies. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; offers pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression solution, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. Additionally, it manufactures, prepares, delivers, and distributes radiopharmaceuticals and related treatments; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
